Could a poop pill curb alcohol cravings in liver disease patients?

NCT ID NCT05548452

Recruiting now Disease control Sponsor: Virginia Commonwealth University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether capsules containing bacteria from healthy people can safely reduce alcohol cravings and drinking in adults with alcohol-related liver disease and cirrhosis. About 80 participants will receive either the bacteria capsules or a placebo, and researchers will track drinking days, cravings, and liver health over several months. The goal is to see if changing gut bacteria can help people drink less and improve their liver condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse alcoholic liver cirrhosis alcoholic liver disease cirrhosis of liver Fibrosis liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER CIRRHOSIS LIVER DISEASE; ALCOHOL-RELATED

Contacts and locations

Locations

Hunter Holmes McGuire VA Medical Center
RECRUITING

Richmond, Virginia, 23249, United States
Virginia Commonwealth University
RECRUITING

Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.